A Novel Drug Targeting Strategy for the Treatment of Inflammatory Bowel Disease: A Molecular Biopharmaceutical Approach

Projektinformationen

TARGETIBDBYPLA2

ID Finanzhilfevereinbarung: 277079

Projekt abgeschlossen

Startdatum 1 Mai 2011

Enddatum 30 April 2015

Finanziert unter

• Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)

Gesamtkosten € 100 000,00

EU-Beitrag € 100 000,00

Koordiniert durch

BEN-GURION UNIVERSITY OF THE NEGEV
Israel